Controversies Challenges Consensus
}

CX showcases most promising vascular innovations

2019-10-29T10:22:37+00:00

CX 2018 Dragons’ Den winner, Kieran Murphy, with the Dragons

The Innovation Showcase yesterday brought together the CX values of education, innovation, and evidence to paint a global picture of vascular entrepreneurship, highlighting the controversies currently threatening the next generation of game-changing products.

Beginning the […]

CX showcases most promising vascular innovations2019-10-29T10:22:37+00:00

Low early mortality and high technical success for novel thoracic stent graft

2018-04-27T10:33:59+01:00

A physician-sponsored investigational device exemption trial on thoracic endovascular aortic repair (TEVAR) using a new thoracic stent graft (Valiant thoracoabdominal aortic aneurysm stent graft, Medtronic), along with its initial 30-day data, was revealed at a Podium 1st presentation at CX 2018 by Thomas Maldonado (New York, USA). […]

Low early mortality and high technical success for novel thoracic stent graft2018-04-27T10:33:59+01:00
Go to Top